This anonymous direct-to-consumer brand operates on a subscription-first model, focusing on nerve health and inflammation support. Its core product aims to alleviate symptoms such as numbness and tingling. The business has a strong and predictable revenue stream, with over 7,500 active subscribers and a significant presence in the United States, the United Kingdom, Australia, and Canada. Primarily utilizing Shopify for sales, its financials reflect total revenue of $2.47M and a net profit of $340K, with a monthly recurring revenue of approximately $275K and a net margin of 14%. Founded to cater to an underserved demographic of adults aged 55-70, the brand delivers long-term enhancement in nerve health through premium supplements. The owners are selling to focus on other ventures, offering a potential buyer the chance to further scale the operation. Critical operational components are outsourced, ensuring streamlined processes with minimal owner involvement averaging 10-15 hours per week. The business holds inventory sufficient to meet demand, with key management tasks in paid media, customer support, and marketing optimization. Numerous growth opportunities exist, such as launching new products, expanding marketing channels, and enhancing the international presence. Assets included in the sale encompass domains, brand collateral, web assets, social media accounts, and more, with 30 days of post-sale support offered to ensure a seamless transition. This business presents a promising acquisition opportunity for those interested in a scalable, subscription-based model in the health and wellness sector, though it requires committed capital as loans are not accepted.